Neumora Therapeutics, INC. (NMRA) — 10-K Filings
All 10-K filings from Neumora Therapeutics, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Neumora Faces MDD Setback, Pivots on Key Neuroscience Programs
— Mar 30, 2026 Risk: high
Neumora Therapeutics, Inc. (NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience. The company is advancing several programs, including na - 10-K Filing — Mar 3, 2025
-
Neumora Therapeutics, Inc. Files 2023 Annual Report on Form 10-K
— Mar 7, 2024 Risk: medium
Neumora Therapeutics, Inc. (NMRA) filed a Annual Report (10-K) with the SEC on March 7, 2024. Neumora Therapeutics, Inc. filed its 2023 Form 10-K on March 7, 20
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX